Injectable Solution
Neuroleptoanalgesic association

FORMULA: Xilazine chlorhydrate (equivalent to base) 20 mg, ketamine chlorhydrate (equivalent to base) 100 mg, atropine sulphate (equivalent to base) 1 mg, excipients q.s. ad 1 mL.

THERAPEUTIC INDICATIONS: The association ketamine-xilazine generates neurolepto­analgesia that permits to effect a safe surgycal handling (abdominal cavity, muscles, castration, deep cleaning of mucous tissues, teeth and surgycal cleaning of abscesses). It provides non dissociative anesthesia. atropine is included (as premedication in surgery) to avoid increase of excesive secretions, reduce bronchial mucus, avoid laryngeal spasm during endotracheal intubation and to prevent the bradycardic effects of ketamine.

DOSAGE AND ADMINISTRATION: Only by intramuscular route, at a rate of  5 mg-10 mg ketamine/kg of body weignt, 1 mg-2 mg xilacine/kg of body weight and 0.05 mg-0.1 mg atropine/kg body weight; which in practice is equivalent to 0.5 mL-1 mL/10 Kg. body weight.

ENGOREPROD 465-1116 20091121